Outcomes following radical cystectomy in Kasr Alaini haspital : Hospital readmission rate,30&90 day morbidity&mortality /
Ahmed Tawakol Eldesoky
Outcomes following radical cystectomy in Kasr Alaini haspital : Hospital readmission rate,30&90 day morbidity&mortality / نتائج مابعد الإستئصال الجذرى للمثانة فى مستشفى القصر العينى : معدل إعادة دخول المستشفى : المضاعفات والوفيات خلال ثلاثين وتسعين يوما Ahmed Tawakol Eldesoky ; Supervised Hesham Badawy , Khaled Mursi Hammoud , Hany Elfayoumy - Cairo : Ahmed Tawakol Eldesoky , 2012 - 70P. : 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Urology
Bladder cancer is the 9th most common cancer diagnosis worldwide with more than 330,000 new cases each year and more than 130.000 deaths per year . At the initial diagnosis of bladder cancer 70% of cases are diagnosed as non - muscle - invasive bladder cancer (NMIBC) and approximately 30% as muscle invasine disease . Radical cystectomy is the standard treatment for patients with muscle - invasive bladder cancer and it is also a valid option for selected patients with high - grade non - muscle - invasive bladder cancer
Bladder cancer Diabetes mellitus Hypertension
Outcomes following radical cystectomy in Kasr Alaini haspital : Hospital readmission rate,30&90 day morbidity&mortality / نتائج مابعد الإستئصال الجذرى للمثانة فى مستشفى القصر العينى : معدل إعادة دخول المستشفى : المضاعفات والوفيات خلال ثلاثين وتسعين يوما Ahmed Tawakol Eldesoky ; Supervised Hesham Badawy , Khaled Mursi Hammoud , Hany Elfayoumy - Cairo : Ahmed Tawakol Eldesoky , 2012 - 70P. : 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Urology
Bladder cancer is the 9th most common cancer diagnosis worldwide with more than 330,000 new cases each year and more than 130.000 deaths per year . At the initial diagnosis of bladder cancer 70% of cases are diagnosed as non - muscle - invasive bladder cancer (NMIBC) and approximately 30% as muscle invasine disease . Radical cystectomy is the standard treatment for patients with muscle - invasive bladder cancer and it is also a valid option for selected patients with high - grade non - muscle - invasive bladder cancer
Bladder cancer Diabetes mellitus Hypertension